Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia
EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia
EHA 2019: Overcoming the "Don’t Eat Me" signal of refractory lymphomas
EHA 2019: Overcoming the "Don’t Eat Me" signal of refractory lymphomas
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
Antibody treatment allows transplant of mismatched stem cells, tissues in mice
Antibody treatment allows transplant of mismatched stem cells, tissues in mice
EHA 2019: Phase 3 randomised study of daratumumab plus D-VTd vs VTd in transplant-eligible newly diagnosed multiple myeloma
EHA 2019: Phase 3 randomised study of daratumumab plus D-VTd vs VTd in transplant-eligible newly diagnosed...
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or...
EHA 2019: Labor is the most frequent outcome in the European Leukemia Net registry of patients with chronic myeloid leukaemia and pregnancy
EHA 2019: Labor is the most frequent outcome in the European Leukemia Net registry of patients with chronic...
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities
EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...
A heart failure drug to treat leukaemia: a promising new therapeutic approach
A heart failure drug to treat leukaemia: a promising new therapeutic approach
SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells
SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation